Interdisciplinary Rheumatology: Rheumatology and Pulmonology

Certain diseases may involve organ systems that cross the boundaries of specialties. For instance, a patient with scleroderma can develop interstitial lung disease, or a patient with relapsing polychondritis can have the clinical manifestation of subglottic stenosis. This book represents a collaboration between specialties, helping clinicians recognize the implications of disease both within their own specialty and in the overlapping specialty. Here, leading experts from the fields of rheumatology and pulmonology provide a masterclass in the care of patients with systemic illnesses that involve the immune system and the lungs.

Key Features:

1. Provides an evidence-based clinical approach to the patient with pulmonary manifestations of rheumatic disease.

2. Details cutting-edge research with input from the world’s leading experts.

3. Discusses possible future directions for research and advancement

Marcy B. Bolster, MDMarcy B. Bolster, MD is a rheumatologist and the Director of the Rheumatology Fellowship Training Program and a member of the Scleroderma Program at the Massachusetts General Hospital (MGH)l, Boston, MA. She is a Professor of Medicine at Harvard Medical School. Her clinical interests lie in scleroderma and systemic autoimmune rheumatic diseases. She was a member of the core leadership group for the American College of Rheumatology Interstitial Lung Disease Guidelines working group. She additionally has a strong interest in medical education across the spectrum of learners, and she has helped train more than 70 rheumatology fellows. She is the recipient of the 2019 American College of Rheumatology Distinguished Program Director Award, the 2019 Partners (now Mass General Brigham) Outstanding Program Director Award, and the 2021 Arthritis Foundation Marian Ropes Lifetime Achievement Award.

Kristin B. Highland MD, MSCRDr. Highland is Vice Chair of the Integrated Hospital Care Institute (Anesthesiology, Emergency Services, Hospital Medicine, Infectious Disease, and Pulmonary/Critical Care) of the Cleveland Clinic and director of the Rheumatic Lung Disease Program. Her clinical and research interests have focused on the pulmonary manifestations of rheumatic lung disease with an emphasis on interstitial lung disease and pulmonary hypertension, particularly in the setting of scleroderma. She is a member of the scientific advisory council of the Pulmonary Hypertension Association and the Scleroderma Foundation and has been active in the American College of Chest Physicians. She has published more than 100 peer-reviewed articles and serves on the editorial board of several international journals including Lancet Respiratory. She is also an associate editor of Respiratory Medicine.